Skip to main content

Malignancies in Dermatology

  • Chapter
  • First Online:
Atlas of PET-CT
  • 738 Accesses

Abstract

Cutaneous melanoma represents 5% of all malignant tumors and its incidence has increased in recent years [1]. Melanoma is aggressive due to its ability to metastasize in early stages of the disease. Early diagnosis is essential for a better prognosis. A four-stage scale (I, II, III, IV) has been proposed by the American Joint Committee on Cancer (AJCC) [2]. PET/CT using FDG may have a role in some steps of the natural history of melanoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag GmbH Germany, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Fanti, S., Farsad, M., Mansi, L., Castellucci, P. (2018). Malignancies in Dermatology. In: Atlas of PET-CT. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57742-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-57742-4_4

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-57740-0

  • Online ISBN: 978-3-662-57742-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics